News Novartis cancer drugs among raft of NICE recommendations NICE recommends funding for lung cancer and skin cancer treatments.
News GSK COPD combination better than AZ rival - trial GSK plans to file triple combination therapy by end of the year.
News Circassia shares plummet following cat allergy therapy failu... Company said the failure could have implications for its other products under development
News UK shows lead in real-world research after lung trial succes... The UK is positioning itself as a one-stop shop for clinical research, following a ground-breaking respiratory "real world" study undertaken by GSK.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
